Trial Profile

A Pharmacodynamic Study to Evaluate the Effects of IMB-1018972 on Myocardial Energetics, Metabolism, and Function in Patients With Type 2 Diabetes

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 08 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Mar 2025 Clinical results from Part 2 of this study are presented in the Imbria Pharmaceuticals Media Release.
29 Mar 2025 According to an Imbria Pharmaceuticals media release, company presented clinical results from Part 2 of the IMPROVE-DiCE Phase 2 trial in a poster presentation at the American College of Cardiology Annual Scientific Session & Expo (ACC.25) in Chicago, IL.
17 Mar 2025 According to an Imbria Pharmaceuticals media release, company will present data from this study at the American College of Cardiology Annual Scientific Session & Expo (ACC.25), taking place in Chicago, IL, from March 29-31, 2025.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com